ERGO SCIENCE CORP
10-Q, EX-27, 2000-11-14
PHARMACEUTICAL PREPARATIONS
Previous: ERGO SCIENCE CORP, 10-Q, 2000-11-14
Next: WORLDWIDE ENTERTAINMENT & SPORTS CORP, 10-Q, 2000-11-14



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                      11,502,238
<SECURITIES>                                18,665,785
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                            21,811,332
<PP&E>                                          74,961
<DEPRECIATION>                                  49,705
<TOTAL-ASSETS>                              30,217,707
<CURRENT-LIABILITIES>                        3,835,996
<BONDS>                                              0
                                0
                                  6,634,311
<COMMON>                                       142,993
<OTHER-SE>                                  19,604,407
<TOTAL-LIABILITY-AND-EQUITY>                30,217,707
<SALES>                                              0
<TOTAL-REVENUES>                             1,401,433
<CGS>                                                0
<TOTAL-COSTS>                                  829,755
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                571,678
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            571,678
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   571,678
<EPS-BASIC>                                        .01
<EPS-DILUTED>                                      .01


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission